Collegium Pharmaceutical, Inc.
DE ˙ DB ˙ US19459J1043
26,00 € ↓ -0,80 (-2,99%)
2026-06-03
DEL PRIS
SecurityDE:354 / Collegium Pharmaceutical, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership35,091 shares
Latest Disclosed Value $ 1,624,713
Alliancebernstein L.p. reports 0.23% increase in ownership of 354 / Collegium Pharmaceutical, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 35,091 shares of Collegium Pharmaceutical, Inc. (DE:354) valued at $968,512 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 35,010 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 0.23% during the quarter. The current value of the position is $912,366 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 35,091 81 0.23 1,625 0.25 0.0005
2026-02-17 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 35,010 -1,000 -2.78 1,621 28.67 0.0005
2025-11-14 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 36,010 0 0.00 1,260 18.33 0.0004
2025-08-14 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 36,010 0 0.00 1,065 -0.93 0.0003
2025-05-15 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 36,010 0 0.00 1,075 4.17 0.0004
2025-02-12 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 36,010 -66,120 -64.74 1,032 -73.87 0.0004
2024-11-14 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 102,130 -28,620 -21.89 3,946 -6.27 0.0013
2024-08-14 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 130,750 0 0.00 4,210 -17.04 0.0015
2024-05-14 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 130,750 -29,040 -18.17 5,076 3.19 0.0018
2024-02-14 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 159,790 11,663 7.87 4,918 48.58 0.0019
2023-11-14 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 148,127 54,227 57.75 3,311 64.11 0.0014
2023-08-15 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 93,900 55,600 145.17 2,018 119.72 0.0008
2023-05-15 2023-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 38,300 -4,954 -11.45 919 -8.47 0.0004
2023-02-15 2022-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,254 -52 -0.12 1,003 44.52 0.0005
2022-11-15 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,306 66 0.15 694 -9.40 0.0003
2022-08-15 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,240 -39 -0.09 766 -13.05 0.0003
2022-05-13 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,279 150 0.35 881 9.31 0.0003
2022-02-14 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,129 -35 -0.08 806 -5.40 0.0003
2021-11-10 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,164 -1,580 -3.53 852 -19.47 0.0003
2021-07-30 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 44,744 0 0.00 1,058 -0.19 0.0004
2021-05-06 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 44,744 1,844 4.30 1,060 23.40 0.0005
2021-02-08 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 42,900 0 0.00 859 -3.81 0.0004
2020-11-12 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 42,900 -61,560 -58.93 893 -51.15 0.0005
2020-08-13 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 104,460 0 0.00 1,828 7.15 0.0011
2020-05-14 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 104,460 -34,050 -24.58 1,706 -40.16 0.0012
2020-02-18 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 138,510 0 0.00 2,851 79.31 0.0016
2019-11-14 2019-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 138,510 5,400 4.06 1,590 -9.14 0.0010
2019-08-14 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 133,110 21,070 18.81 1,750 3.18 0.0011
2019-05-14 2019-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 112,040 13,990 14.27 1,696 0.71 0.0011
2019-02-13 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 98,050 60,850 163.58 1,684 207.30 0.0013
2018-11-08 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 37,200 0 0.00 548 -38.22 0.0004
2018-08-13 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 37,200 1,900 5.38 887 -1.66 0.0006
2018-05-14 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 35,300 7,700 27.90 902 77.21 0.0007
2018-02-13 2017-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 27,600 0 0.00 509 75.52 0.0004
2017-11-13 2017-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 27,600 0 0.00 290 -15.94 0.0002
2017-08-10 2017-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 27,600 12,000 76.92 345 119.75 0.0003
2017-05-11 2017-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,600 0 0.00 157 -35.39 0.0001
2017-02-13 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,600 4,300 38.05 243 11.47 0.0002
2016-11-10 2016-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 11,300 1,000 9.71 218 78.69 0.0002
2016-08-11 2016-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 10,300 10,300 122 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.